Our Sponsors
IKCC is committed to open and transparent partnerships with the healthcare industry in accordance with our Donors Policy. Multi-sourced funding allows us to maintain our independence and integrity as a patient organisation while collaborating with stakeholders, including patient organisations, medical experts and the healthcare industry, and focus on our vision – to reduce the global burden of kidney cancer.
2026 Sponsors:
IKCC Donors Policy
International Kidney Cancer Coalition (IKCC) is the global patient organisation dedicated to kidney cancer. Initiated in 2009 and incorporated as a foundation in 2014, IKCC is focused on improving kidney cancer research, treatment, care and survivorship in collaboration with the global network of IKCC Partner Organisations. Coordinated action against kidney cancer on a global scale demands the engagement of a wide range of partners, including patient organisations, patient advocates, healthcare professionals, international agencies, NGOs, foundations, corporations, individuals and others. IKCC recognises the importance of its industry funders and their contributions to achieving the mission to reduce the global burden of kidney cancer.
The IKCC Donors Policy applies to all potential relations with any company from any industry. It addresses donations, grants or sponsorships to the Coalition, both financial and/or in-kind support. The IKCC Donors Policy is based on the UICC’s Partnerships with Donors Policy. Its ambition is to implement a model promoting mutually beneficial collaborations, while managing any potential conflicts of interests. It ensures IKCC has a consistent and transparent approach to developing and maintaining external funding sources and provides a set of principles which allow the Coalition to maintain its independence, credibility and integrity.